Here are few links on Trump Administration and health policy:
- Fierce Healthcare: Where do Harris and Trump stand on health policy?
- Here.
- STAT: Donald Trump returns with big ambitions to shake up health care.
- The Guardian [UK]: Trump's queasy prescription to 'make America health again' takes shape.
- Here.
- WSJ reviews Trump economics more generally - e.g. tariffs, tax cuts, potential inflation, etc.
- Here.
##
Court Postures
One topic not mentioned above that could affect a few issues is how the Trump administration fights, or doesn't fight, the government side of some legal battles. For example, from the Obama to Trump to Biden administration, there were several 180 degree flip flops on whether to include "transgender" under the heading of "sex discrimination." ANother grand flip flop was from MCIT (Medicare Coverage for Innovative Technology) to TCET (Transitional Coverage for Emerging Technology) between Trump 2020 and Biden 2021.
Current legal cases include Braidwood v Becerra, where the moving party would like to eliminate USPTF recommendations as requirements for preventive services, an issue it is up to the government to defend in the way it chooses. Similarly the government could opt to take one of various responses to the FDA LDT litigation being pushed forward by ACLA.
###
Leadership Nominations
Leadership of HHS, CMS, FDA, etc., will be up for grabs, and we may not know more until mid-spring.
My blog of January 25, 2017, just after the inauguration, contained several then-contemporary links to news report about Dr. Shiong-Soon (a biotech billionaire who owns the LA Times) and potential positions in the administration.
Returns?
One senior health policy executive in the Trump administration is Joe Grogan, who has remained active and public on health policy topics. E.g., he was interviewed at length on a second Trump administration in Stat Plus on October 16. He was one of just three Trump administration interviewed in a panel at the IOP (Institute of Politics) on October 15. See also his 30-minute interview on health policy at Andreessen-Horowitz (January 2024). He's also been outspoken on drug pricing policy and innovation (here).
##
The Guardian article cites some "Project 2025" policies that the Trump campaign disavowed.
##